[Sodium ozagrel].
Kitagawa
Yasuhisa
Y
Department of Neurology, Tokai University Hachioji Hospital.
D000208:Acute Disease; D002544:Cerebral Infarction / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008689:Methacrylates / Q000627:therapeutic use*
D004791:Enzyme Inhibitors; D005343:Fibrinolytic Agents; D008689:Methacrylates; C034364:ozagrel